¼¼°è ´ç´¢º´ Ä¡·á ±â±â ½ÃÀå º¸°í¼­(2024³â)
Diabetes Care Devices Global Market Report 2024
»óǰÄÚµå : 1429395
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 400 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,000 £Ü 7,234,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,500 £Ü 10,851,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,469,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

´ç´¢º´ Ä¡·á ±â±â ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³âµ¿¾È »ó´çÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. 2028³â º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 7.6%¸¦ ³ªÅ¸³¾ Àü¸ÁÀ̸ç 932¾ï ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ¿¹»óµÇ´Â ¼ºÀåÀº R&D ÅõÀÚ Áõ°¡, Á¶»ç Çù·Â, Áúº´ ºÎ´ã Áõ°¡, Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê, ±â¼ú ¹ßÀü°ú °ü·ÃµÉ ¼ö ÀÖ½À´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀº ½ºÆ½À̾ø´Â Ç÷´ç °Ë»ç, Æ÷µµ´ç ¹ÝÀÀ¼º Àν¶¸°(GRI), Àΰø ÃéÀå °³¹ß, ±âÁ¸ Àν¶¸° ÁÖ»ç±âÀÇ Àüȯ, Áö´ÉÇü Ç÷´ç ÃøÁ¤±â ¿Ü¿¡µµ Âø¿ë °¡´É ¹× ¸ð¹ÙÀÏ Ç÷´ç ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÇ ÃâÇöÀ» Æ÷ÇÔÇÕ´Ï´Ù.

´ç´¢º´ Ä¡·á ±â±â ½ÃÀåÀÇ ¿¹»ó ¼ºÀåÀº °Ç°­ °ü¸® ºñ¿ë Áõ°¡·Î ÃËÁøµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °Ç°­ °ü¸® ÁöÃâ¿¡´Â °³ÀÎ, Áö¿ª»çȸ, ±¹°¡, ¼¼°è ±Ô¸ð¿Í °°Àº ´Ù¾çÇÑ ¼öÁØ¿¡¼­ ƯÁ¤ ±â°£ ³»¿¡ ÀÇ·á °ü·Ã ¼­ºñ½º, Á¦Ç° ¹× Ȱµ¿¿¡ ¼ÒºñµÈ ÃÑ ±Ý¾×ÀÌ Æ÷ÇԵ˴ϴÙ. ÇコÄÉ¾î ºñ¿ë Áõ°¡´Â ÇコÄɾî Á¢±Ù¼ºÀÇ Çâ»ó°ú ´ç´¢º´ À¯º´·ü Áõ°¡¿Í ÇÔ²² ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¸¦ °¡Á®¿É´Ï´Ù. ÀÌ´Â Æ÷µµ´ç ¸ð´ÏÅ͸µ ½Ã½ºÅÛ, Àν¶¸° Åõ¿© ÀåÄ¡, µðÁöÅÐ Çコ ¼Ö·ç¼Ç °³¼± µî ´ç´¢º´ Ä¡·á ±â±âÀÇ Áøº¸¸¦ °¡Á®¿É´Ï´Ù. ¿¹¸¦ µé¾î, ±¹°¡ Åë°è±¹Àº 2023³â 5¿ù ¿µ±¹ÀÇ °Ç°­ °ü¸® ÁöÃâÀÌ ¸í¸ñ»ó 9.4% Áõ°¡ÇßÀ¸¸ç ½ÇÁúÀûÀ¸·Î 9.7% Áõ°¡Çß´Ù°í º¸°íÇß½À´Ï´Ù. 2021³â ¿µ±¹ÀÇ °Ç°­ °ü¸® ÁöÃâ ÃѾ×Àº 3,672¾ï 5,000¸¸ ´Þ·¯(2,807¾ï ÆÄ¿îµå)¿´½À´Ï´Ù., °°Àº ÇØÀÇ ÀǾàǰ ÁöÃâÀº 518¾ï 4,000¸¸ ´Þ·¯(396¾ï ÆÄ¿îµå)¿¡ À̸£·¶½À´Ï´Ù. °Ô´Ù°¡ ¿¹¹æÀÇ·á ÁöÃâÀº Àü³âÀÇ 2¹è ÀÌ»óÀ¸·Î Áõ°¡Çß°í, 2021³â¿¡´Â 459¾ï 3,000¸¸ ´Þ·¯(351¾ï ÆÄ¿îµå)¿¡ ´ÞÇß½À´Ï´Ù. µû¶ó¼­ °Ç°­ °ü¸® ÁöÃâÀÇ ±ÞÁõÀÌ °¡±î¿î ¹Ì·¡¿¡ ´ç´¢º´ Ä¡·á ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼ÒºñÀÚÀÇ ÃëÇâÀÇ º¯È­¿Í ¹Ù»Û ¶óÀÌÇÁ ½ºÅ¸ÀÏÀº ƯÈ÷ ´ç´¢º´°ú °°Àº ºñ°¨¿°¼º ÁúȯÀÇ ºÐ¾ß¿¡¼­ ¼¼°è Àα¸ÀÇ Áúº´ ÇÁ·ÎÆÄÀÏÀÇ º¯È­¿¡ ±â¿©ÇÕ´Ï´Ù. Àå½Ã°£ ³ëµ¿, Á¦ÇÑµÈ ½Åü Ȱµ¿, °Ç°­¿¡ ÇØ·Î¿î ½Ä»ýȰ ¹× À½ÁÖ ½À°ü°ú °°Àº ¿äÀÎÀº ´ç´¢º´ÀÇ ÀÌȯÀ²¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. 2021³â 7¿ù ¹ßÇàµÈ ±¹Á¦ ´ç´¢º´ ¿¬¸ÍÀÇ IDF ´ç´¢º´ ¾ÆÆ²¶ó½º Á¦10ÆÇ¿¡ µû¸£¸é ´ç´¢º´À» °®°í »ç´Â ¼¼°è ÃßÁ¤ Àα¸´Â 2030³â±îÁö 6¾ï 4,300¸¸ ¸íÀ¸·Î Áõ°¡ÇßÀ¸¸ç, 2045³â±îÁö ´õ 7 ¾ï 8,300¸¸ ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ´Â ³ëÀÎ ¼ºÀÎ ¾à 5¾ï 3,700¸¸ ¸í¿¡¼­ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀÎÀº ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå Á¦Ç°/¼­ºñ½º ºÐ¼® - Á¦Ç°/¼­ºñ½º ¿¹

Á¦4Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦5Àå °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦6Àå ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

Á¦7Àå ½ÃÀå ¼¼ºÐÈ­

Á¦8Àå Áö¿ª ¹× ±¹°¡ ºÐ¼®

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦10Àå Áß±¹ ½ÃÀå

Á¦11Àå Àεµ ½ÃÀå

Á¦12Àå ÀϺ» ½ÃÀå

Á¦13Àå È£ÁÖ ½ÃÀå

Á¦14Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦15Àå Çѱ¹ ½ÃÀå

Á¦16Àå ¹æ±Û¶óµ¥½Ã ½ÃÀå

Á¦17Àå ű¹ ½ÃÀå

Á¦18Àå º£Æ®³² ½ÃÀå

Á¦19Àå ¸»·¹ÀÌ½Ã¾Æ ½ÃÀå

Á¦20Àå ½Ì°¡Æ÷¸£ ½ÃÀå

Á¦21Àå Çʸ®ÇÉ ½ÃÀå

Á¦22Àå È«Äá ½ÃÀå

Á¦23Àå ´ºÁú·£µå ½ÃÀå

Á¦24Àå ¼­À¯·´ ½ÃÀå

Á¦25Àå ¿µ±¹ ½ÃÀå

Á¦26Àå µ¶ÀÏ ½ÃÀå

Á¦27Àå ÇÁ¶û½º ½ÃÀå

Á¦28Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦29Àå ½ºÆäÀÎ ½ÃÀå

Á¦30Àå ¿À½ºÆ®¸®¾Æ ½ÃÀå

Á¦31Àå º§±â¿¡ ½ÃÀå

Á¦32Àå µ§¸¶Å© ½ÃÀå

Á¦33Àå Çɶõµå ½ÃÀå

Á¦34Àå ¾ÆÀÏ·£µå ½ÃÀå

Á¦35Àå ³×´ú¶õµå ½ÃÀå

Á¦36Àå ³ë¸£¿þÀÌ ½ÃÀå

Á¦37Àå Æ÷¸£Åõ°¥ ½ÃÀå

Á¦38Àå ½º¿þµ§ ½ÃÀå

Á¦39Àå ½ºÀ§½º ½ÃÀå

Á¦40Àå µ¿À¯·´ ½ÃÀå

Á¦41Àå ·¯½Ã¾Æ ½ÃÀå

Á¦42Àå üÄÚ°øÈ­±¹ ½ÃÀå

Á¦43Àå Æú¶õµå ½ÃÀå

Á¦44Àå ·ç¸¶´Ï¾Æ ½ÃÀå

Á¦45Àå ¿ìÅ©¶óÀ̳ª ½ÃÀå

Á¦46Àå ºÏ¹Ì ½ÃÀå

Á¦47Àå ¹Ì±¹ ½ÃÀå

Á¦48Àå ij³ª´Ù ½ÃÀå

Á¦49Àå ¸ß½ÃÄÚ ½ÃÀå

Á¦50Àå ³²¹Ì ½ÃÀå

Á¦51Àå ºê¶óÁú ½ÃÀå

Á¦52Àå Ä¥·¹ ½ÃÀå

Á¦53Àå ¾Æ¸£ÇîÆ¼³ª ½ÃÀå

Á¦54Àå ÄÝ·Òºñ¾Æ ½ÃÀå

Á¦55Àå Æä·ç ½ÃÀå

Á¦56Àå Áßµ¿½ÃÀå

Á¦57Àå »ç¿ìµð¾Æ¶óºñ¾Æ ½ÃÀå

Á¦58Àå À̽º¶ó¿¤ ½ÃÀå

Á¦59Àå À̶õ ½ÃÀå

Á¦60Àå ÅÍŰ ½ÃÀå

Á¦61Àå ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE) ½ÃÀå

Á¦62Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦63Àå ÀÌÁýÆ® ½ÃÀå

Á¦64Àå ³ªÀÌÁö¸®¾Æ ½ÃÀå

Á¦65Àå ³²¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦66Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦67Àå ±âŸ ¼±µµÀûÀ̰í Çõ½ÅÀûÀÎ ±â¾÷

Á¦68Àå °æÀï º¥Ä¡¸¶Å·

Á¦69Àå °æÀï ´ë½Ãº¸µå

Á¦70Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦71Àå ¹Ì·¡ Àü¸Á°ú °¡´É¼º ºÐ¼®

Á¦72Àå ºÎ·Ï

BJH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Diabetes care devices are employed to monitor and manage blood glucose levels in individuals with diabetes.

The primary categories of diabetes care devices include blood glucose test strips, insulin pens, syringes, pumps and injectors, lancing devices and equipment, continuous glucose monitoring devices and equipment, and blood glucose meters. Insulin pens are devices equipped with a needle to administer insulin into the subcutaneous tissue. Expenditures can be classified as public or private, and the products utilized fall into the categories of instruments/equipment and disposables. Testing methods encompass both point-of-care (POC) testing and non-point-of-care (POC) testing, with diverse end-users, including hospitals and clinics, diagnostic laboratories, and others.

The diabetes care devices market research report is one of a series of new reports from The Business Research Company that provides diabetes care devices market statistics, including diabetes care devices industry global market size, regional shares, competitors with a diabetes care devices market share, detailed diabetes care devices market segments, market trends and opportunities, and any further data you may need to thrive in the diabetes care devices industry. This diabetes care devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The diabetes care devices market size has grown strongly in recent years. It will grow from $64.27 billion in 2023 to $69.46 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The expansion observed in the historical period can be ascribed to the growing prevalence of diabetes, economic development, reforms in public health insurance, a rise in the elderly population, and increased healthcare spending.

The diabetes care devices market size is expected to see strong growth in the next few years. It will grow to $93.2 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%. The anticipated growth in the forecast period can be linked to the rise in research and development investments, collaborations in research, an increase in the burden of diseases, government initiatives, and technological advancements. Key trends expected in the forecast period encompass stick-free glucose testing, glucose-responsive insulins (GRIs), artificial pancreas development, a shift away from traditional insulin syringes, and the emergence of wearable and mobile glucose monitoring systems, along with intelligent glucose meters.

The anticipated growth of the diabetes care device market is expected to be driven by increasing healthcare expenditures. Healthcare expenditures encompass the total amount spent on healthcare-related services, products, and activities within a specified period, at various levels such as individual, community, national, or global. The rising healthcare expenditures, combined with enhanced healthcare accessibility and the growing prevalence of diabetes, result in increased investments in research and development. This, in turn, leads to advancements in diabetes care devices, including improved glucose monitoring systems, insulin delivery devices, and digital health solutions. As an illustration, the Office for National Statistics reported a 9.4% increase in healthcare spending in the UK in nominal terms and a 9.7% increase in real terms in May 2023. The UK's total healthcare expenditure in 2021 was $367.25 billion (£280.7 billion), with pharmaceutical expenditure reaching $51.84 billion (£39.6 billion) in the same year. Additionally, spending on preventive care more than doubled from the previous year, reaching $45.93 billion (£35.1 billion) in 2021. Therefore, the upsurge in healthcare expenditure is expected to drive the growth of the diabetes care device market in the foreseeable future.

Changing consumer preferences and busy lifestyles are contributing to shifts in the disease profile of the global population, particularly in the realm of non-communicable diseases such as diabetes. Factors such as extended working hours, limited physical activity, and unhealthy dietary and drinking habits play a significant role in the prevalence of diabetes. According to the International Diabetes Federation's IDF Diabetes Atlas 10th edition in July 2021, the estimated global population living with diabetes is projected to rise to 643 million by 2030 and further increase to 783 million by 2045. This marks an increase from approximately 537 million adults aged 20 to 79 living with diabetes in 2021. These factors are anticipated to contribute to the growth of the market in the forecast period.

Major players in the diabetes care devices market are strategically focusing on the development of innovative products to enhance market profitability, exemplified by the introduction of the Medtronic Extended Infusion Set. This infusion set, manufactured by Medtronic PLC, a US-based medical equipment company, functions as a tube delivering insulin from the pump to the body and is engineered for a wear duration of up to 7 days. The Medtronic Extended Infusion Set was launched in select European countries in April 2021, with its initial availability in Finland and Belgium. The product incorporates advanced technology and alternative materials, allowing for an extended usage period compared to other Medtronic infusion sets, typically approved for 2-3 days of use. Further expansion into additional European countries is part of the gradual rollout plan.

In the pursuit of innovative advancements, pharmaceutical companies are actively investing in the development and commercialization of glucose-responsive insulins (GRIs), presenting significant opportunities for the evolution of novel insulin delivery devices. Notably, Novo Nordisk, a Danish pharmaceutical company, has committed an investment of $800 million to acquire the UK biotech start-up Ziylo for the development of GRIs. Simultaneously, companies such as Eli Lily and Sanofi have initiated research projects aimed at the development of GRIs. These smart insulins automatically activate or deactivate in response to fluctuating glucose levels in the blood, enhancing the effectiveness of diabetes treatment and reducing the occurrence of hyperglycemia and hypoglycemia.

Major companies operating in the diabetes care devices market report are Becton, Dickinson and Company, Novo Nordisk A/S, Roche Holding AG, Nipro Corporation, HTL-STREFA Inc., ARKRAY, Terumo Corporation, Owen Mumford, Ypsomed AG, Vogt Medical, Sanofi India, Biocon Ltd., Mehar healthcare, Johnson & Johnson, GE Healthcare, Covidien Healthcare, Philips Healthcare India, Shandong WeiGao Group Medical Polymer Company Limited, Yuwell medical equipment & supply Co, Olympus Medical Systems, Hitachi Medico, Nihon Koden, Fukuda Denshi, Medtronic, Emperra GmbH E-Health, Novo Nordisk A/S, Insujet, Eli Lilly, Fresenius Medical Care, Siemens, Stryker, Teleflex Medical, LifeScan, Ascensia Diabetes Care, Tandem Diabetes Care, Dexcom Inc., SocialDiabetes, Dottli, Themis Bioscience, Ok biotech, Acon Laboratories, Bayer AG, AgaMatrix.

North America was the largest region in the global diabetes care devices market in 2023. Western Europe was the second largest region in the global diabetes care devices market. The regions covered in the diabetes care devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the diabetes care devices market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa

The diabetes care devices market consists of sales of blood glucose monitoring devices, insulin delivery devices, smart insulin pens and others that are used for monitor and treat diabetes patient. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diabetes Care Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diabetes care devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for diabetes care devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The diabetes care devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Scope

Markets Covered:

Table of Contents

1. Executive Summary

2. Diabetes Care Devices Market Characteristics

3. Diabetes Care Devices Product/Service Analysis -Product/Service Examples

4. Diabetes Care Devices Market Trends And Strategies

5. Diabetes Care Devices Market - Macro Economic Scenario

6. Global Diabetes Care Devices Market Size and Growth

7. Diabetes Care Devices Market Segmentation

8. Diabetes Care Devices Market Regional And Country Analysis

9. Asia-Pacific Diabetes Care Devices Market

10. China Diabetes Care Devices Market

11. India Diabetes Care Devices Market

12. Japan Diabetes Care Devices Market

13. Australia Diabetes Care Devices Market

14. Indonesia Diabetes Care Devices Market

15. South Korea Diabetes Care Devices Market

16. Bangladesh Diabetes Care Devices Market

17. Thailand Diabetes Care Devices Market

18. Vietnam Diabetes Care Devices Market

19. Malaysia Diabetes Care Devices Market

20. Singapore Diabetes Care Devices Market

21. Philippines Diabetes Care Devices Market

22. Hong kong Diabetes Care Devices Market

23. New Zealand Diabetes Care Devices Market

24. Western Europe Diabetes Care Devices Market

25. UK Diabetes Care Devices Market

26. Germany Diabetes Care Devices Market

27. France Diabetes Care Devices Market

28. Italy Diabetes Care Devices Market

29. Spain Diabetes Care Devices Market

30. Austria Diabetes Care Devices Market

31. Belgium Diabetes Care Devices Market

32. Denmark Diabetes Care Devices Market

33. Finland Diabetes Care Devices Market

34. Ireland Diabetes Care Devices Market

35. Netherlands Diabetes Care Devices Market

36. Norway Diabetes Care Devices Market

37. Portugal Diabetes Care Devices Market

38. Sweden Diabetes Care Devices Market

39. Switzerland Diabetes Care Devices Market

40. Eastern Europe Diabetes Care Devices Market

41. Russia Diabetes Care Devices Market

42. Czech Republic Diabetes Care Devices Market

43. Poland Diabetes Care Devices Market

44. Romania Diabetes Care Devices Market

45. Ukraine Diabetes Care Devices Market

46. North America Diabetes Care Devices Market

47. USA Diabetes Care Devices Market

48. Canada Diabetes Care Devices Market

49. Mexico Diabetes Care Devices Market

50. South America Diabetes Care Devices Market

51. Brazil Diabetes Care Devices Market

52. Chile Diabetes Care Devices Market

53. Argentina Diabetes Care Devices Market

54. Colombia Diabetes Care Devices Market

55. Peru Diabetes Care Devices Market

56. Middle East Diabetes Care Devices Market

57. Saudi Arabia Diabetes Care Devices Market

58. Israel Diabetes Care Devices Market

59. Iran Diabetes Care Devices Market

60. Turkey Diabetes Care Devices Market

61. United Arab Emirates Diabetes Care Devices Market

62. Africa Diabetes Care Devices Market

63. Egypt Diabetes Care Devices Market

64. Nigeria Diabetes Care Devices Market

65. South Africa Diabetes Care Devices Market

66. Diabetes Care Devices Market Competitive Landscape And Company Profiles

67. Diabetes Care Devices Market Other Major And Innovative Companies

68. Global Diabetes Care Devices Market Competitive Benchmarking

69. Global Diabetes Care Devices Market Competitive Dashboard

70. Key Mergers And Acquisitions In The Diabetes Care Devices Market

71. Diabetes Care Devices Market Future Outlook and Potential Analysis

72. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â